Business Standard

Wednesday, January 08, 2025 | 05:11 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Over 300 pharma, healthcare companies eligible for new Covid loans: Crisil

Hospitals to gain most with up to 3.5% dip on cost of funds; may add half a million beds, says rating agency

pharma, drugs
Premium

Representational image

Abhijit Lele Mumbai
As many as 354 CRISIL-rated companies, predominantly pharmaceutical firms and hospitals, with an aggregate bank exposure of Rs 40,000 crore will be eligible for Covid loans from lenders under RBI's liquidity facility.
 

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in